Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Fitch

Showing results (131-140 of 139) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 139 results.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 25, 2008
Bone formation during distraction osteogenesis is dependent on both VEGFR1 and VEGFR2 signalingKimberly A Jacobsen, Zainab S Al-Aql, Chao Wan, et al.
Bioorganic & Medicinal Chemistry Letters|September 11, 2010
Exploration of piperidine-4-yl-aminopyrimidines as HIV-1 reverse transcriptase inhibitors. N-Phenyl derivatives with broad potency against resistant mutant virusesGuozhi Tang, Denis J Kertesz, Minmin Yang, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 13, 2012
Using chimeric mice with humanized livers to predict human drug metabolism and a drug-drug interactionToshihiko Nishimura, Toshiko Nishimura, Yajing Hu, et al.
Gastrointestinal Endoscopy|April 10, 2013
Metabolomic-derived novel cyst fluid biomarkers for pancreatic cysts: glucose and kynurenineWalter G Park, Manhong Wu, Raffick Bowen, et al.
Expert Opinion on Investigational Drugs|December 10, 2016
RRx-001: a systemically non-toxic M2-to-M1 macrophage stimulating and prosensitizing agent in Phase II clinical trialsBryan Oronsky, Ramasamy Paulmurugan, Kira Foygel, et al.
The Lancet. Oncology|August 23, 2015
Safety and activity of RRx-001 in patients with advanced cancer: a first-in-human, open-label, dose-escalation phase 1 studyTony Reid, Bryan Oronsky, Jan Scicinski, et al.
Journal of Medicinal Chemistry|October 14, 2015
Novel Series of Dihydropyridinone P2X7 Receptor AntagonistsFrancisco Lopez-Tapia, Keith A M Walker, Christine Brotherton-Pleiss, et al.
Science (New York, N.Y.)|April 17, 1999
Science over politicsR P Lanza, K J Arrow, J Axelrod, et al.
The Washington Post|December 5, 2002
Nobel laureates' letter to President BushK J Arrow, J Axelrod, B Benacerraf, et al.
Pageof 14

Showing results (131-140 of 139) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 139 results.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 25, 2008
Bone formation during distraction osteogenesis is dependent on both VEGFR1 and VEGFR2 signalingKimberly A Jacobsen, Zainab S Al-Aql, Chao Wan, et al.
Bioorganic & Medicinal Chemistry Letters|September 11, 2010
Exploration of piperidine-4-yl-aminopyrimidines as HIV-1 reverse transcriptase inhibitors. N-Phenyl derivatives with broad potency against resistant mutant virusesGuozhi Tang, Denis J Kertesz, Minmin Yang, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 13, 2012
Using chimeric mice with humanized livers to predict human drug metabolism and a drug-drug interactionToshihiko Nishimura, Toshiko Nishimura, Yajing Hu, et al.
Gastrointestinal Endoscopy|April 10, 2013
Metabolomic-derived novel cyst fluid biomarkers for pancreatic cysts: glucose and kynurenineWalter G Park, Manhong Wu, Raffick Bowen, et al.
Expert Opinion on Investigational Drugs|December 10, 2016
RRx-001: a systemically non-toxic M2-to-M1 macrophage stimulating and prosensitizing agent in Phase II clinical trialsBryan Oronsky, Ramasamy Paulmurugan, Kira Foygel, et al.
The Lancet. Oncology|August 23, 2015
Safety and activity of RRx-001 in patients with advanced cancer: a first-in-human, open-label, dose-escalation phase 1 studyTony Reid, Bryan Oronsky, Jan Scicinski, et al.
Journal of Medicinal Chemistry|October 14, 2015
Novel Series of Dihydropyridinone P2X7 Receptor AntagonistsFrancisco Lopez-Tapia, Keith A M Walker, Christine Brotherton-Pleiss, et al.
Science (New York, N.Y.)|April 17, 1999
Science over politicsR P Lanza, K J Arrow, J Axelrod, et al.
The Washington Post|December 5, 2002
Nobel laureates' letter to President BushK J Arrow, J Axelrod, B Benacerraf, et al.
Pageof 14